Skip to main content

Table 6 Amounts necessary for the acquisition of vaccines by the PAI in Ecuador and percentage of Imports of vaccines in relation to local production, Source PAI, prepared by the Author [70]

From: Vaccine market and production capabilities in the Americas

Vaccine name Revolving fund via EPI Enfarma / Inspi % of imports 2013 % Imports 2016
BCG $ 89.647   100% 100%
MMR $ 852.194   100% 100%
MR $ 105.344   100% 100%
Polio Vaccine $ 402.780   100% 100%
Rotavirus Vaccine $ 4.011.333   100% 100%
Pneumococcal vaccine $ 819.275   100% 100%
Immunoglobulin HB. $ 8.807   100% 100%
Chickenpox vaccine $ 5.129.735   100% 100%
Yellow fever vaccine $ 1.585.111   100% 100%
Influenza $ 6.644.748   100% 100%
Trivalent influenza $ 3.743.625   100% 100%
Pediatric trivalent influenza $ 1.032.000   100% 100%
Conjugated Pneumococcal vaccine $ 15.272.250   100% 100%
DT adults   $ 247.200 39% 100%
Anti-meningococcal   $ 29.960 100% 100%
Hep B   $ 292.500 100% 100%
Pediatric Hep B   $ 25.500 100% 100%
Pentavalent   $ 3.431.000 100% 100%
DPT   $ 92.000 0% 100%
DT Pediatric   $ 72.000 0% 100%
Total $ 39.696.850 $ 4.190.160 88% 100%